Connecticut Drug and Alcohol Inpatient Treatment Licensing

Author: A. Ant, CADC-II, Licensing & Accreditation Expert

Disclaimer: This content is provided for general informational purposes only and should not be construed as legal, regulatory, or licensing advice. Requirements change frequently. Consult qualified professionals for guidance specific to your situation.

Apply now: request the initial application by email from the DPH Facility Licensure Processing Unit, DPH.FLISLPU@ct.gov | Questions: DPH Facility Licensing and Investigations Section, 860-509-7400

A private residential addiction program in Connecticut usually needs Certificate of Need approval before it can hold a license, and since July 1, 2026 both decisions come out of the same department. Under Regs. Conn. State Agencies 19a-495-570(c)(1), an SA facility can’t be “constructed, expanded or licensed to operate” until it has applied for and received approval under the state’s CON sections “when applicable.” The rule still names the long-gone Commission on Hospitals and Health Care and section 19a-154, which is the CON statute now numbered 19a-638. The license itself comes from the Connecticut Department of Public Health (DPH), Facility Licensing and Investigations Section (FLIS), and DPH’s Health Systems Planning unit now runs CON after Public Act 26-68 moved the program out of the Office of Health Strategy.

This guide covers residential treatment and residential detox under the DPH category “Facilities for the Care or Treatment of Substance Abusive Persons,” which DPH shortens to SA. Outpatient SA programs have their own guide, Connecticut Drug and Alcohol Outpatient Treatment Licensing, and every program type in the state is summarized on the Connecticut Behavioral Health Licensing overview.

CON Review Now Sits Inside DPH

The statutes and DPH’s own CON page are the basis for this section. The conclusion that a new private residential program falls under CON is our reading of how those pieces fit.

Conn. Gen. Stat. 19a-638 requires CON approval for “the establishment of a new health care facility” and, separately, for an increase in a facility’s licensed bed capacity. Item (H) of the definition in 19a-630(10) is “substance abuse treatment facilities,” named outright. Read together, those two sections put a new residential SUD program under review unless an exemption applies. The exemptions that come closest are written for nonprofits. Section 19a-638(b)(14) exempts a nonprofit provider that “has a contract with, or is certified or licensed to provide a service for, a state agency” for a service that would otherwise need CON, and (b)(12) covers “not-for-profit outpatient clinics” licensed under chapter 368v. A for-profit residential startup fits neither, and the mental health bed-increase exemption in (b)(23) only ran “on or before June 30, 2026.” Expect CON to be the first long-lead item on your calendar, ahead of the license packet.

The program changed hands this year. DPH’s Certificate of Need page says the functions, powers and duties of the CON program “transferred to DPH effective July 1, 2026,” and applications go through the DPH CON web portal at dphconwebportal.ct.gov. According to the legislature’s Office of Legislative Research, PA 26-68 also builds a new, generally streamlined CON process that begins in July 2027, with decisions made by a panel of the DPH and DSS commissioners and the OPM secretary. If your filing will land in mid-2027, ask DPH which process will apply to it.

The Residential Classifications That Appear on an SA License

The table below paraphrases definitions in 19a-495-570(a) and (b) as DPH posts the rule. Nothing in it is our own categorization.

The SA rule sorts services into named classifications, and 570(c)(4)(C) requires each license to “list on its face the level of service to be provided.” Four classifications are residential.

Classification	What the rule describes
Residential Detoxification and Evaluation	A residential service for “the management of detoxification from a substance or substances of abuse”
Intensive Treatment	Residential care with “twenty-four hour a day supervision and services”
Intermediate and Long Term Treatment and Rehabilitation	Structured residential group living with ongoing evaluation and activities that support the client’s integration into the community
Care and Rehabilitation	A residential service offering “a structured and supervised group living experience”

The rule’s history line ends with an amendment dated April 29, 1999, and nowhere does it use an ASAM level number. A referral source asking whether your house runs at Level 3.5 or 3.7 won’t find the answer on the license. Connecticut does certify ASAM levels for programs that bill Medicaid, but that certification sits outside the DPH license and we don’t handle it.

An option that doesn’t depend on either state agency is CARF’s ASAM Level of Care Certification. CARF says certification “is available for adult Levels of Care 3.1, 3.5, and 3.7,” and ASAM describes the program as delivered in partnership with CARF. Nothing about it will show up on the DPH license. A referral source who wants proof can open CARF’s provider search and filter by the certified level. For a program holding the Intensive Treatment classification, 3.7 is the level we would look at. DPH has never tied its classifications to ASAM numbers, so that match is our own judgment. Neither CARF nor ASAM describes the certification as reaching withdrawal management, which leaves a Residential Detoxification and Evaluation unit outside it.

MOUD Access Under the SA Rule

We read 19a-495-570 for any duty to offer MOUD, allow it or refer for it and found nothing. The rule’s closest brush with the subject is a urine screen provision listing opiates and methadone among the substances to test for. We also found no other Connecticut statute requiring a licensed facility to admit people already taking MOUD. That silence isn’t an invitation to turn those patients away, and in our experience referral partners stop sending people to programs that do.

Methadone lives in a different classification, which the rule calls Chemical Maintenance Treatment. Opioid treatment programs follow their own federal and state requirements, so a residential program admitting a methadone patient needs a written arrangement with a licensed OTP that will keep dosing that person. Federal rules on buprenorphine loosened in 2023. Writing to registrants on January 12, 2023, DEA stated that “A DATA-Waiver registration is no longer required to treat patients with buprenorphine for opioid use disorder.” Connecticut puts one step in front of the DEA number: the Department of Consumer Protection (DCP) must issue a state Controlled Substance Registration first, and DCP’s FAQ says DEA requires it “prior to obtaining a new DEA number with a Connecticut address.” For naltrexone, SAMHSA says it “can be prescribed and administered by any practitioner licensed to prescribe medications.”

Ketamine for Residents With Co-Occurring Depression or PTSD

Ketamine appears nowhere in the SA rule or on the DPH pages we read. Everything in this section is how we interpret the licensing rule, the controlled substance statutes and the nursing law, so describe your plan to FLIS in writing before the first dose.

The SA rule doesn’t list medications by name, and ketamine is not a classification of its own. In our view a licensed residential program can add it as part of medical care for residents whose depression or PTSD persists alongside their addiction. The rule still treats program changes as a paperwork event. Section 570(c)(4)(G) requires written notice to DPH at least ninety days before a change in services, and because the license lists its classifications on its face, we would send that notice even though no new classification is involved. Learning in month three that DPH reads it differently is an expensive way to find out.

Your classification decides how comfortable this is. A Residential Detoxification and Evaluation unit must have a physician directing medical services and at least one registered nurse on each shift (570(m)(7)). The other residential classifications only require a direct care staff member in each building when a client is present. Post-dose observation calls for someone with clinical training in the room, so a house without nurses would need to book that coverage for every treatment day.

Registrations, Monitoring and Who Gives the Dose

Ketamine is Schedule III under 21 CFR 1308.13(c)(7). Connecticut’s registration statute, Conn. Gen. Stat. 21a-317, reaches every practitioner who “distributes, administers or dispenses any controlled substance,” and DCP describes the registration as location specific, so the prescriber needs one tied to the program’s address. If a visiting prescriber brings ketamine to the house instead of keeping it at the registered address, 21a-317 calls for telling DCP ahead of time. Anyone holding that registration also signs up for CPMRS, the state prescription monitoring system, and a lookup there comes before any prescription running past a 72-hour supply of a Schedule II through V drug. Reporting is murkier. Section 21a-254(j) is written around dispensed prescriptions and says nothing clear about a dose a nurse gives in the building, so put that question to DCP.

Connecticut registered nurses carry out “the medical regimen under the direction of a licensed physician, dentist or advanced practice registered nurse” (20-87a(a)), and we found no Board of Examiners for Nursing position on RN-administered ketamine. An APRN can prescribe, though for the first three years of licensure, and until at least 2,000 hours are complete, the APRN works in collaboration with a physician, and the written collaboration terms spell out how much Schedule II and III prescribing the APRN can do. After that, independent practice follows written notice to the Commissioner (20-87a(b)). Esketamine has its own federal rule. The FDA medication guide says Spravato “can only be administered at healthcare settings certified in the SPRAVATO REMS program,” and someone has to keep eyes on the patient for a minimum of 2 hours afterward.

Who Is a Candidate

No FDA label lists ketamine as a treatment for addiction of any kind, and a ketamine series does nothing to meet a resident’s need for buprenorphine, methadone or naltrexone. We would wait until withdrawal is well behind the resident and the mood or trauma symptoms have held on through standard treatment, and a history of misusing dissociatives argues against it.

Carrying the Series Past Discharge

Most ketamine series outlast a residential stay, so plan the continuation when you plan the first dose. Once the resident goes home, the remaining sessions belong to an outpatient practice. Connecticut’s professional corporation law, chapter 594a, limits shareholders to people licensed for the same professional service, with allowed combinations that pair physicians with physician assistants or APRNs. Our search turned up no Connecticut statute, rule or court ruling forbidding a non-physician from owning the business side of a medical clinic, which leaves the question open rather than answered. In our view the safer structure is a professional corporation owned by the physician, with a separately owned management company handling the nonclinical side under contract. For the clinic’s own licensing and ownership questions, go to the ketamine section of Connecticut Drug and Alcohol Outpatient Treatment Licensing.

Get a lawyer to review any referral flow between your beds and that clinic before the first patient makes the trip. EKRA, the federal anti-kickback law for recovery and treatment settings codified at 18 U.S.C. 220, punishes remuneration for referrals to a clinical treatment facility, which it defines to include non-hospital settings providing detoxification or outpatient treatment under state licensure, and the statute allows a fine of as much as $200,000, a prison term of as much as 10 years, or both, for each occurrence. We did not find an enacted Connecticut patient brokering statute, which leaves the federal law as the one to design around.

Required Roles and Payroll for a Residential SA Program

The SA rule fixes some roles and leaves the rest to the program. A residential detox unit needs a physician designated to direct medical services, an RN designated to direct nursing, at least one registered nurse on every shift, and a physician on call whenever none is on site. In every residential building the rule wants a direct care worker on site any time a client is known to be there, backed by staff who can be reached. Intensive Treatment programs must have a psychiatrist or psychologist available for diagnosis and evaluation when needed, and a pharmacist supervises pharmaceutical services where the rule calls for them. Counselors only have to meet the qualifications in the facility’s own job descriptions, and the rule sets no counselor-to-client ratio.

State law fills in the counselor side. Conn. Gen. Stat. 20-74s says no one may practice alcohol and drug counseling without a license, and DPH issues two credentials. The Licensed Alcohol and Drug Counselor (LADC) requires a master’s degree with at least eighteen graduate semester hours in counseling subjects. The Certified Alcohol and Drug Counselor (CAC) does not. Each one asks for 360 education hours, 300 hours of supervised practical training and three years of supervised work before the IC&RC exam, though for the LADC a master’s degree stands in for one of the three years.

Counselors cost more here than the national norm. Connecticut’s substance abuse, behavioral disorder, and mental health counselors earned a median of $63,590 in the May 2025 BLS wage survey (OEWS). The figure for the whole country is $59,350, and the middle half of Connecticut counselors earn between $49,250 and $80,040. A clinical director and four counselors, all paid at the state median, would come to about $317,950 a year before nursing, direct care staff or benefits. Treat that number as a ceiling to plan against, since few Connecticut residential programs end up paying it in full. The counselor law itself makes room for a leaner mix. Section 20-74s exempts paid counselors working under supervision, and both credentials require three years of supervised work, which lets one LADC in the clinical director’s chair oversee CACs and credential-seekers who accept lower pay in exchange for the supervised hours they need. Built this way, a Connecticut clinical team commonly comes in 40 to 60 percent under the payroll of an all-LADC staff. On the nursing side, one RN per shift can lead a team of LPNs in the detox unit rather than every nurse being an RN. We size the final roster to your census and the classifications on your license.

Accreditation and the License Term

The SA rule never mentions an accreditor. We found no provision giving CARF or Joint Commission accreditation deemed status for an SA license and no reduced inspection schedule for accredited residential SUD programs. The four-year cycle in 19a-491(e) is written for outpatient clinics. Accreditation still carries weight with referral sources, and the CARF certification described above is the only way we know to show an ASAM level that the DPH license won’t display.

The 1999 rule and the statute part ways on how long a license lasts. Under 570(c)(4)(A) a license runs “for a period not to exceed one year.” The statute, 19a-493(a), gives it “two years or a fraction thereof,” and we read the later statute as controlling. Renewals go through the Connecticut eLicense portal.

How to Submit Your DPH SA License Application

No online form exists for a first SA license. The FLIS Facility Licensing page directs first-time applicants to the Facility Licensure Processing Unit, reachable at DPH.FLISLPU@ct.gov, for the initial application packet. That unit also processes ownership changes, service changes and bed changes. DPH lists Alice.Martinez@ct.gov for regulation questions about SA facilities, and the FLIS main line is 860-509-7400. Paper goes to the Department of Public Health, 410 Capitol Avenue, Hartford, CT 06134.

Under 570(c)(3)(A), the application is made in writing on DPH’s forms, signed and notarized. It travels with proof of zoning and building code compliance, the local fire marshal’s certificate, ownership statements, proof of public liability coverage, an org chart, the classifications you are requesting, and a staff list by name and title. The FLIS page posts the supporting pieces, including Ownership Forms 1 (partnerships and LLCs), 2 (trusts) and 3 (corporations), a fire marshal certificate form, a sample Certificate of Insurance and the Attestation of Licensure Applicant. Before a first license DPH conducts “a scheduled inspection and investigation” (19a-493(a)). We found no SA license fee in 19a-491 and no DPH fee schedule, so ask the unit what it will charge when you request the packet. The rule puts the renewal deadline 30 days ahead of expiration.

Where Connecticut Residential Projects Lose Time

The schedule risk we see most often is treating CON as something to file once the building is ready. The SA rule holds back the license until any required CON approval is in hand, so an operator who signs a lease first pays rent through the entire review. The fire marshal’s certificate is the other common wait, because local officials inspect on their own calendar and DPH wants the certificate in the application.

Frequently Asked Questions

Working CON into the schedule for a Connecticut residential program? Let us help map it out.

Sources

• Connecticut DPH, Facility Licensing and Investigations Section: Facility Licensing (application request, forms, contacts, eLicense renewals) (checked October 13, 2026)
• Connecticut DPH: Certificate of Need (program transfer to DPH, July 1, 2026) (checked October 13, 2026)
• Regs. Conn. State Agencies 19a-495-570, DPH Public Health Code: Private freestanding facilities for substance abusive or dependent persons (PDF) (checked October 13, 2026)
• Regs. Conn. State Agencies 19a-495-570, via Cornell LII: Licensure of private freestanding facilities for substance abusive or dependent persons (checked October 13, 2026)
• Conn. Gen. Stat. 19a-491, via Justia: License required, fees, outpatient clinic inspection cycle (checked October 13, 2026)
• Conn. Gen. Stat. 19a-493, via Justia: License term and initial inspection (checked October 13, 2026)
• Conn. Gen. Stat. 19a-630, via Justia: Health care facility definition (checked October 13, 2026)
• Conn. Gen. Stat. 19a-638, via Justia: Certificate of Need requirements and exemptions (checked October 13, 2026)
• Connecticut Office of Legislative Research: 2026 Acts Affecting Health Professions and Institutions, 2026-R-0080 (PDF) (checked October 13, 2026)
• Connecticut DSS: 1115 SUD certification standards and process, April 12, 2024 (PDF) (checked October 13, 2026)
• CARF: ASAM Level of Care Certification (checked October 13, 2026)
• CARF: Find a Provider (ASAM Level of Care filters) (checked October 13, 2026)
• ASAM: Level of Care Certification (checked October 13, 2026)
• DEA Diversion Control Division: Dear Registrant letter on the DATA-Waiver, January 12, 2023 (PDF) (checked October 13, 2026)
• Connecticut DCP, Drug Control Division: Controlled Substance Registration for Practitioner FAQ (checked October 13, 2026)
• Connecticut DCP: Prescription Monitoring Program, prescriber information (checked October 13, 2026)
• Conn. Gen. Stat. 21a-317, via Justia: Controlled substance registration (checked October 13, 2026)
• Conn. Gen. Stat. 21a-254, via Justia: Prescription monitoring reporting (checked October 13, 2026)
• Conn. Gen. Stat. 20-87a, via Justia: Nursing practice and APRN collaboration (checked October 13, 2026)
• Conn. Gen. Stat. 20-74s, via Justia: Alcohol and drug counselors (checked October 13, 2026)
• Connecticut DPH: Alcohol and drug counselor licensure requirements (LADC) (checked October 13, 2026)
• Connecticut DPH: Alcohol and drug counselor certification requirements (CAC) (checked October 13, 2026)
• Conn. Gen. Stat. chapter 594a, Connecticut General Assembly: Professional service corporations (checked October 13, 2026)
• SAMHSA: Naltrexone (checked October 13, 2026)
• 21 CFR 1308.13(c)(7), via Cornell LII: Schedule III, ketamine (checked October 13, 2026)
• U.S. FDA: Spravato prescribing information and Medication Guide (PDF) (checked October 13, 2026)
• 18 U.S.C. 220, via Cornell LII: Illegal remunerations for referrals to recovery homes, clinical treatment facilities, and laboratories (checked October 13, 2026)
• U.S. Bureau of Labor Statistics, OEWS May 2025: Occupational Employment and Wage Statistics tables (SOC 21-1018) (checked October 13, 2026)